Advyzon Investment Management’s Transmedics TMDX Stock Holding History

Advyzon Investment Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$318K	Buy	+3,196	New	+$417K	0.03%	515

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advyzon Investment Management's TMDX Position: Q1 2026 in Review

Advyzon Investment Management opened a new position in Transmedics (TMDX) in Q1 2026: 3,196 shares worth $318K. The stake represents 0.03% of the portfolio and ranks #515 among its holdings.

414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Advyzon Investment Management held 3,196 shares of Transmedics worth $318K as of Q1 2026.
Transmedics was a new Advyzon Investment Management position in Q1 2026.
Transmedics made up 0.03% of Advyzon Investment Management's portfolio in Q1 2026, its #515 holding.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Advyzon Investment Management's 13F filing for Q1 2026, filed 12 May 2026.